FDA grants De Novo authorization to Virtuoso Robotic System for bladder tumor resection
FDA action · Urology Times · 2026-11-10. Number 1 in the UrologyWatch Top 5 for November 11, 2026.
The FDA granted De Novo authorization to the Virtuoso Robotic System, a device intended for robotic resection of bladder tumors.
Why it matters: A new dedicated robotic platform for transurethral bladder tumor resection adds to options for NMIBC management.
Source: Urology Times
Loading today's edition…